Streetbeat News

Stock Prices

FATE

Wedbush analyst David Nierengarten has maintained a Neutral rating on Fate Therapeutics (NASDAQ:FATE) and lowered the price target from $6 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:50 pm

BIIB

Biogen shares are trading lower following the company's Q3 financial results and weak FY23 guidance. Wedbush has maintained a Neutral rating on the stock and lowered its price target from $266 to $239.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:47 pm

GOLD

Barrick Gold (NYSE:GOLD) has seen unusual options activity, with a significant number of investors adopting a bullish approach. The company's options scanner highlighted 10 extraordinary options activities, with 60% leaning bullish and 40% bearish. The mean open interest for Barrick Gold options trades today is 15709.67 with a total volume of 21,285.00. Analysts from Raymond James and BMO Capital maintain an Outperform rating on Barrick Gold, with target prices of $25 and $30 respectively.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 3:47 pm

ATO

Atmos Energy reported better-than-expected Q3 EPS results and issued FY24 EPS guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:46 pm

AMZN

Amazon.com, Inc. (NASDAQ:AMZN) is downsizing its music division, including the audio streaming service and digital music store, as part of its ongoing cost-cutting measures. The cuts are specifically impacting the editorial and audio content team of Amazon Music. The company did not disclose the exact number of jobs affected. This move may indicate a strategic pivot towards enhancing its Prime Video service. AMZN shares traded lower by 0.31% at $141.63 on the last check Thursday.

Portfolio Pulse from Anusuya Lahiri

November 09, 2023 | 3:43 pm

CLMT

Calumet Specialty Products Partners LP (NASDAQ:CLMT) reported a Q3 FY23 sales decline of 1.3% YoY to $1.15 billion, beating the consensus of $1.04 billion. Net income per unit was $1.26, surpassing the consensus of 26 cents. Adjusted EBITDA was $75.5 million, down from $127 million a year ago. The company faced operational issues in Shreveport and Montana, which cost over $50 million of lost profit opportunity. Despite this, CLMT shares are trading higher by 18.15% at $15.36 premarket on Thursday.

Portfolio Pulse from Akanksha Bakshi

November 09, 2023 | 3:42 pm

BILL

BILL (NYSE:BILL), a financial automation software company, has responded to market rumors about a potential acquisition, stating that it is not pursuing any such acquisition at this time.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:41 pm

MFC

Manulife Financial reported its Q3 adjusted EPS results, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:41 pm

CTVA

Corteva Inc. reported lower than expected Q3 revenue results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 3:40 pm

BDX

Becton, Dickinson and Company (BDX) reported Q4 adjusted EPS of $3.42, slightly missing the consensus of $3.43. Sales were $5.09 billion, up 6.8% Y/Y, beating the consensus of $5.02 billion. The company declared a quarterly dividend of $0.95 per share, up 4.4% from the previous quarter. However, BDX shares are down 8.24% after the company issued lower than expected FY24 revenue and EPS guidance.

Portfolio Pulse from Vandana Singh

November 09, 2023 | 3:39 pm